News
Stevin Prize for Immunologist Ton Schumacher
Immunologist Ton Schumacher of the Netherlands Cancer Institute, also Professor at Leiden University Medical Center (LUMC), is being awarded the Stevin Prize.
Fall edition Venture Challenge now open for applications
As of this week, enterprising researchers can submit their candidacy for the Fall edition of the Venture Challenge, which NWO organises on behalf of the Ministry of Economic Affairs and Climate.
Venture Challenge alumnus Core Life Analytics Closes €1M Series A Deal
The Netherlands-based data analytics company, Core Life Analytics, has closed a €1m Series A financing round. The investor team is composed of BOM Brabant Ventures, Utrecht Holdings and TechFund One.
Novalis Biotech Incubation to invest in LS@W alumnus Cergentis
Novalis Biotech Incubation, a Belgian venture capital investment fund, is investing seed capital in Cergentis for an undisclosed amount.
Spring edition Venture Challenge starts in the summer
Six innovative teams were selected this spring to participate in the Venture Challenge, a coaching programme for start-ups in the Life Sciences & Health that is being organised for the first time under the auspices of
Venture Challenge alumnus Predica Diagnostics is supported by the RedMedtech Discovery Fund
May 8, 2020 RedMedTech Discovery Fund supports CervicaDx development
Corona bridging loan for startups, scale-ups likely available from end of April
Last Tuesday, April 7, the Dutch cabinet announced that it will initially make € 100 million available for bridging loans to start-ups, scale-ups and innovative SMEs that have been financially affected by the impact of the corona crisis.
Venture Challenge Alumnus AGILeBiotics contributes to fight against future pandemic infections (e.g. COVID-19)
Today we are reminded that antibiotics are an important part of treatment regiments not only for severe antiviral infections, such as COVID-19, but also other hospitalized patients with multidrug-resistant (MDR) secondary infections
AGILeBiotics appoints new CEO Victor Schut
Victor Schut has been appointed as the new Chief Executive Officer (CEO) of AGILeBiotics and co-founder Dr. Andreas A. Bastian has now taken on the role of Chief Operating Officer (COO).